These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16807265)

  • 1. Sildenafil treatment for portopulmonary hypertension.
    Reichenberger F; Voswinckel R; Steveling E; Enke B; Kreckel A; Olschewski H; Grimminger F; Seeger W; Ghofrani HA
    Eur Respir J; 2006 Sep; 28(3):563-7. PubMed ID: 16807265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
    Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
    Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
    Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS
    J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
    Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled iloprost plus oral sildenafil in patients with severe pulmonary arterial hypertension delays the need for lung transplantation.
    Lopez-Meseguer M; Berastegui C; Monforte V; Bravo C; Domingo E; Roman A
    Transplant Proc; 2013; 45(6):2347-50. PubMed ID: 23953548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
    Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
    Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
    Garg N; Sharma MK; Sinha N
    Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension.
    Ghofrani HA; Rose F; Schermuly RT; Olschewski H; Wiedemann R; Kreckel A; Weissmann N; Ghofrani S; Enke B; Seeger W; Grimminger F
    J Am Coll Cardiol; 2003 Jul; 42(1):158-64. PubMed ID: 12849677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic oral sildenafil therapy in severe pulmonary artery hypertension.
    Kothari SS; Duggal B
    Indian Heart J; 2002; 54(4):404-9. PubMed ID: 12462669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and long-term effects of inhaled iloprost in portopulmonary hypertension.
    Melgosa MT; Ricci GL; García-Pagan JC; Blanco I; Escribano P; Abraldes JG; Roca J; Bosch J; Barberà JA
    Liver Transpl; 2010 Mar; 16(3):348-56. PubMed ID: 20209595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
    Madden BP; Sheth A; Wilde M; Ong YE
    Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension.
    Reichenberger F; Voswinckel R; Enke B; Rutsch M; El Fechtali E; Schmehl T; Olschewski H; Schermuly R; Weissmann N; Ghofrani HA; Grimminger F; Mayer E; Seeger W
    Eur Respir J; 2007 Nov; 30(5):922-7. PubMed ID: 17690123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study.
    Humpl T; Reyes JT; Holtby H; Stephens D; Adatia I
    Circulation; 2005 Jun; 111(24):3274-80. PubMed ID: 15956137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose oral sildenafil for patients with pulmonary hypertension: a cost-effective solution in countries with limited resources.
    Vida VL; Gaitan G; Quezada E; Barnoya J; Castañeda AR
    Cardiol Young; 2007 Feb; 17(1):72-7. PubMed ID: 17184573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil add-on therapy in paediatric pulmonary arterial hypertension, experiences of a national referral centre.
    Douwes JM; Roofthooft MT; Van Loon RL; Ploegstra MJ; Bartelds B; Hillege HL; Berger RM
    Heart; 2014 Feb; 100(3):224-30. PubMed ID: 24390161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil improves dynamic vascular function in the brain: studies in patients with pulmonary hypertension.
    Rosengarten B; Schermuly RT; Voswinckel R; Kohstall MG; Olschewski H; Weissmann N; Seeger W; Kaps M; Grimminger F; Ghofrani HA
    Cerebrovasc Dis; 2006; 21(3):194-200. PubMed ID: 16388195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of clinical efficacy of sildenafil in patients with primary pulmonary hypertension.
    Sastry BK; Narasimhan C; Reddy NK; Anand B; Prakash GS; Raju PR; Kumar DN
    Indian Heart J; 2002; 54(4):410-4. PubMed ID: 12462670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study.
    Rubin LJ; Badesch DB; Fleming TR; Galiè N; Simonneau G; Ghofrani HA; Oakes M; Layton G; Serdarevic-Pehar M; McLaughlin VV; Barst RJ;
    Chest; 2011 Nov; 140(5):1274-1283. PubMed ID: 21546436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of sildenafil in Chinese patients with pulmonary arterial hypertension.
    Xu XQ; Jing ZC; Zhang JH; Wu Y; Wang Y; Jiang X; Wang ZX; Sun YG; Pu JL; Yang YJ
    Hypertens Res; 2009 Oct; 32(10):911-5. PubMed ID: 19644505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.